In another study [43], human epidermal growth factor receptor 2 (+) BT 474, a well-known breast cancer biomarker, was detected utilizing the HER 2 antibody with a LOD of 4.7 × 105 exosomes/μL. Here, ERBB2 is linked to breast carcinoma.